(Health-NewsWire.Net, March 17, 2016 ) New report, “Emerging Pharmaceutical Market in Indonesia and Philippines 100% Foreign Direct Investment (FDI) in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies”, provides an in-depth analysis of trends, issues and challenges in the pharmaceutical market in Indonesia and in the Philippines. The report analyzes the overall pharma market structure in these countries, provides competitive benchmarking for the leading companies, and analyzes the M&A and strategic partnerships that shape the Indonesian and Filipino pharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
The Indonesian pharmaceutical industry exhibited high growth after the government announced a plan to allow 100% foreign ownership of drug firms to increase overseas investment in the sector and thereby raise the volume and quality of local production. The Philippines’ pharmaceutical industry on the other hand witnessed slow growth due to a drug pricing law implemented by the government. The Indonesian pharmaceutical industry has noticeably changed since the approval of the Universally Accessible Cheaper and Quality Medicines Act that includes the Maximum Drug Retail Price (MDRP) scheme. MDRP called for a 50% price reduction for more than 100 drugs.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=111071
Indonesia and the Philippines recently joined the ranks of the top 20 most populated countries in the world, meaning they offer huge patient populations. There has been a rise in the incidence of chronic diseases like diabetes, obesity, and cardiovascular disease. Emerging markets such as Indonesia must address the population’s rising demand for healthcare and significant unmet medical needs.
The Philippines’ CRO market is gaining attention globally due to its favorable regulatory environment and huge patient base offered by the country’s large population. However, the Indonesian CRO market is not as favorable for drugs registration procedures, which currently take 300 days after submission to the Indonesian Food and Drug Monitoring Agency (BPOM). Indonesia and the Philippines currently account for a tiny share of the global CMO market but are set to capitalize on increasing outsourcing opportunities from western countries.
Scope
Overall pharma market structure in Indonesia and the Philippines Indonesia and the Philippines’ pharmaceutical market characterizations, including market size, major regulatory bodies, pricing and reimbursement issues, major distribution channel and intellectual property rights Indonesia and the Philippines’ CMO and CRO market analysis Analysis of the leading segments within the Indonesia and Filipino pharmaceutical industries Competitive benchmarking of leading companies in the pharmaceutical markets Key M&A activities and strategic partnership deals that have taken place between 2004 to 2011
Reasons to buy
Develop market-entry and market expansion strategies by identifying the leading emerging markets poised for strong growth. Devise a more tailored country strategy through the understanding of key drivers and barriers of the country’s pharmaceutical market. Develop key strategic initiatives by understanding the key focus areas of leading companies. Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Browse Detail Report With TOC @ http://www.researchmoz.us/emerging-pharmaceutical-market-in-indonesia-and-philippines-100-foreign-direct-investment-in-indonesia-and-extensive-insurance-coverage-in-the-philippines-attract-foreign-pharma-companies-report.html
Table of Contents
1 Table of Contents 1 Table of Contents 5 1.1 List of Tables 7 1.2 List of Figures 9
2 Emerging Pharmaceutical Market: Indonesia and the Philippines –Introduction 11
3 Emerging Pharmaceutical Market: Indonesia and the Philippines – Industry Characteristics 12 3.1 Market Size and Market Forecast 12 3.1.1 Indonesia 12 3.1.2 The Philippines 14 3.2 Market Share by Therapeutic Area 15 3.2.1 Indonesia 15 3.2.2 The Philippines 17 3.3 Market Share – Branded versus Generic Market Share 18 3.3.1 Indonesia 18 3.3.2 The Philippines 19 3.4 Top Five Pharmaceutical Companies, Market Share 20 3.4.1 Indonesia 20 3.4.2 The Philippines 26 3.5 R&D Expenditure and Innovations 32 3.5.1 Indonesia 32 3.5.2 The Philippines 32 3.6 Trends and Recent Developments in Foreign Direct Investment 33 3.6.1 Indonesia 33 3.6.2 The Philippines 33 3.7 Marketing Distribution Channel 34 3.7.1 Indonesia 34 3.7.2 The Philippines 35 3.8 PESTLE Analysis 36 3.8.1 Indonesia 36 3.8.2 The Philippines 38
4 Emerging Pharmaceutical Market: Indonesia and the Philippines – Macroeconomic Environment 41 4.1 Demographic Analysis 41 4.1.1 Population Size, Growth, and Structure 41 4.1.2 Mortality Rate 45 4.1.3 Population Ageing and Health 45 4.2 GDP 46 4.2.1 Indonesia 46 4.2.2 The Philippines 47 4.3 Per Capita Income 48 4.3.1 Indonesia 48 4.3.2 The Philippines 49 4.4 Income Status 50 4.4.1 Indonesia 50 4.4.2 The Philippines 50 4.5 Healthcare Expenditure 51 4.5.1 Context 51 4.6 Healthcare Infrastructure 52 4.6.1 Context 52
5 Emerging Pharmaceutical Market: Indonesia and The Philippines – Healthcare Regulation 53 5.1 Pharmaceutical Regulation in Indonesia and the Philippines 53 5.1.1 Healthcare System Structure 53 5.2 Drug Approval Process 55 5.2.1 Indonesia 55 5.2.2 The Philippines 56 5.3 Patents and Generics (IPR) 57 5.3.1 Context 57 5.3.2 Analytical Framework 58 5.4 Health Insurance Coverage 59 5.4.1 Indonesia 59 5.4.2 The Philippines 59 5.5 Clinical Trials 60 5.5.1 Context 60 5.5.2 Analytical Framework 61 5.6 Pricing and Reimbursement 62 5.6.1 Context 62
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=111071
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|